Literature DB >> 2722944

Treatment of displaced subcapital fractures with the Charnley-Hastings hemiarthroplasty.

P J Rae1, J P Hodgkinson, T H Meadows, D R Davies, E J Hargadon.   

Abstract

Between December 1982 and June 1986, 98 displaced subcapital femoral neck fractures were treated using the Charnley-Hastings bipolar hemiarthroplasty. Although the patients were elderly, often with associated medical problems, the operation was well tolerated and the mortality at one and six months was 14.4% and 24.5% respectively. Fifty-four hips were reviewed after an average follow-up of 33 months; 64.8% of patients had a good or excellent result. The fair or poor results were seen mainly in patients with poor pre-operative mobility and multiple medical problems. A significant cause of morbidity was dislocation (two interprosthetic) which occurred in six hips. There were two cases of deep sepsis but neither patient was fit for further surgery. There were no cases of acetabular erosion requiring revision surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2722944     DOI: 10.1302/0301-620X.71B3.2722944

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

1.  The Monk Hard-Top prosthesis for displaced intracapsular fractures of the femoral neck.

Authors:  H B Casserly; B Healy
Journal:  Ir J Med Sci       Date:  1991-01       Impact factor: 1.568

Review 2.  Unipolar versus bipolar hemiarthroplasty for displaced femoral neck fractures: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Zhiwei Jia; Fan Ding; Yaohong Wu; Wei Li; Haifeng Li; Deli Wang; Qing He; Dike Ruan
Journal:  J Orthop Surg Res       Date:  2015-01-24       Impact factor: 2.359

3.  Transtrochanteric approach can provide better postoperative care and lower complication rate in the treatment of hip fractures.

Authors:  Safa Gursoy; Mehmet Emin Simsek; Mustafa Akkaya; Metin Dogan; Murat Bozkurt
Journal:  Clin Interv Aging       Date:  2019-01-14       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.